Reassessing the two-year rodent carcinogenicity bioassay: A review of the applicability to human risk and current perspectives
- 1 February 2014
- journal article
- review article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 68 (1) , 108-118
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needsMutagenesis, 2011
- Application of the U.S. EPA Mode of Action Framework for Purposes of Guiding Future Research: A Case Study Involving the Oral Carcinogenicity of Hexavalent ChromiumToxicological Sciences, 2010
- The History of Tumor VirologyCancer Research, 2008
- A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicalsJournal of Molecular Graphics and Modelling, 2008
- Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistanceCell Metabolism, 2006
- Dose-dependent transitions in mechanisms of toxicity: case studiesToxicology and Applied Pharmacology, 2004
- Human Carcinogenic Risk Evaluation, Part V: The National Toxicology Program Vision for Assessing the Human Carcinogenic Hazard of ChemicalsToxicological Sciences, 2004
- Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung CancerPharmacological Reviews, 2003
- Pathology and Tissue Sampling Protocols for Rodent Carcinogenicity Studies: Time for RevisionToxicologic Pathology, 2000
- The decision-point approach for systematic carcinogen testingFood and Cosmetics Toxicology, 1981